Mukesh Kumar Manickasamy
Overview
Explore the profile of Mukesh Kumar Manickasamy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manickasamy M, Kumar A, BharathwajChetty B, AlQahtani M, Abbas M, Alqahtani A, et al.
Life Sci
. 2024 Aug;
354:122943.
PMID: 39117139
Despite significant advancements in chemotherapy, effective treatments for advanced cancer stages remain largely elusive due to chemoresistance. Resistance to anticancer agents in cancer cells can arise through various mechanisms, including...
2.
Sajeev A, BharathwajChetty B, Manickasamy M, AlQahtani M, Abbas M, Shakibaei M, et al.
Front Oncol
. 2024 Jul;
14:1383939.
PMID: 39077471
Ovarian cancer (OVC) is one of the most common causes of cancer-related deaths in women worldwide. Despite advancements in detection and therapy, the prognosis of OVC remains poor due to...
3.
Kumar A, BharathwajChetty B, Manickasamy M, Unnikrishnan J, AlQahtani M, Abbas M, et al.
Pharmacol Res
. 2024 Apr;
203:107167.
PMID: 38599470
Cancer has become a burgeoning global healthcare concern marked by its exponential growth and significant economic ramifications. Though advancements in the treatment modalities have increased the overall survival and quality...
4.
Manickasamy M, Jayaprakash S, Girisa S, Kumar A, Lam H, Okina E, et al.
Discov Oncol
. 2024 Feb;
15(1):41.
PMID: 38372868
Colorectal cancer (CRC) stands as one of the most prevalent form of cancer globally, causing a significant number of deaths, surpassing 0.9 million in the year 2020. According to GLOBOCAN...
5.
Manickasamy M, Sajeev A, BharathwajChetty B, AlQahtani M, Abbas M, Hegde M, et al.
Cell Mol Life Sci
. 2024 Feb;
81(1):78.
PMID: 38334807
Hematological malignancies (HM) represent a subset of neoplasms affecting the blood, bone marrow, and lymphatic systems, categorized primarily into leukemia, lymphoma, and multiple myeloma. Their prognosis varies considerably, with a...